Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
06/2006
06/28/2006CN1795190A Compounds and methods for the treatment or prevention of flavivirus infections
06/28/2006CN1795172A Continuous process for preparing caprolactam
06/28/2006CN1795171A Continuous process for preparing caprolactam
06/28/2006CN1261434C Method for separating high-purity galanthamine from short-tube lycoris crude extract
06/28/2006CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
06/27/2006US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss
06/22/2006WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof
06/22/2006US20060135762 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide
06/22/2006CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof
06/21/2006EP1670768A1 Compounds and methods for treating dyslipidemia
06/21/2006EP1670456A2 Compounds, compositions and methods
06/21/2006EP1501516B1 A process for the preparation of benazepril hydrochloride
06/21/2006CN1260229C Method for separating lycoramine from plant extract
06/21/2006CN1260228C Method for separating galanthamine from plant extract
06/20/2006US7064211 Hemiasterlin derivatives and uses thereof
06/20/2006US7064200 Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
06/20/2006US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy
06/20/2006US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
06/15/2006WO2006039383A3 Synthesis by chiral diamine-mediated asymmetric alkylation
06/15/2006US20060128752 Chemical compounds
06/14/2006CN1259310C Process for extracting and separating caprolactam from amide oil
06/13/2006US7060819 Hydrogenation using hydrogenation catalyst; distillation
06/08/2006WO2006060225A2 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds
06/08/2006US20060122170 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
06/08/2006US20060122169 Succinoylamino benzodiazepines as inhibitors of Abeta protein production
06/08/2006US20060121090 Ocular compositions that increases the activity of gelatinase a in ocular cells
06/07/2006EP1664088A2 Hemiasterlin derivatives and uses thereof
06/07/2006EP1663996A1 (thio)carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists
06/07/2006EP1663984A2 Process for preparation of benazepril
06/07/2006EP1663201A1 A use of novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
06/07/2006CN1781908A Process for preparing epsilon-hexanolactam by catalyzing cyclohexanone-oxime rearranging
06/01/2006WO2006057460A1 Nitrogen-containing fused ring compound and use thereof
06/01/2006WO2006056696A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
06/01/2006WO2006056695A1 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof
06/01/2006WO2006056339A1 A process for the preparation of (s)-(+)-10,11-dihydro-10-hydroxy-5h-dibenz (b,f) azepine-5-carboxyamide
06/01/2006CA2595305A1 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
06/01/2006CA2589147A1 A process for the preparation of (s)-(+)-10,11-dihydro-10-hydroxy-5h-dibenz (b,f) azepine-5-carboxyamide
06/01/2006CA2585990A1 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof
05/2006
05/31/2006EP1660454A1 Azacyclic compounds as inhibitors of sensory neurone specific channels
05/31/2006EP1660436A1 Cathepsin inhibitors
05/31/2006EP1210332B1 Bleach boosting components, compositions and laundry methods
05/31/2006CN1780819A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same
05/31/2006CN1778796A Production of hexyl lactam in ion liquid
05/31/2006CN1778795A Production of hexyl lactam
05/30/2006US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides
05/30/2006US7053084 Antagonist for preventing the deposits of amyloid protein, for treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; (2R,3S) N1-[1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-allyl-butanediamide
05/30/2006US7053081 Cyclic malonamides as inhibitors of A-β protein production
05/30/2006CA2157668C Tricyclic 2,3,4,5-tetrahydro-1h-3-benzazepines, their use and preparation
05/26/2006WO2006053683A2 Gene silencing using sense dna and antisense rna hybrid constructs coupled to peptides facilitating the uptake into cells
05/26/2006WO2006053674A2 A process for the preparation of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxyamide
05/26/2006CA2587486A1 A process for the preparation of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxyamide
05/25/2006US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/25/2006US20060111339 Novel oral general anesthetics and metabolitically resistant anticonvulsants
05/24/2006CN1777423A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
05/24/2006CN1775752A Optical pure diamide compound and its use
05/24/2006CN1257161C Meptazinol prodrug and its salts and its production method
05/23/2006US7049326 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/23/2006US7049311 Pyrrolbenzodiazepines
05/18/2006US20060106009 Use of caboxamides for the treatment of tinnitus
05/18/2006CA2586370A1 Constrained compounds as cgrp-receptor antagonists
05/17/2006EP1656352A1 6-(2,2,2-TRIFLUOROETHYLAMINO)-7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO d AZEPINE AS A 5-HT sb 2c /sb RECEPTOR AGONIST
05/16/2006US7045622 Process for producing lactam
05/16/2006CA2204261C Improved method for preparing opipramol
05/11/2006US20060096869 Apparatus and process for the synthesis of hydrogen peroxide directly from hydrogen and oxygen
05/10/2006EP1656002A2 Organic light emitting device
05/09/2006US7041662 Substituted benzo [b] azepin-2-one compounds
05/08/2006CA2497031A1 Farnesyl dibenzodiazepinones, processes for their production and their use as pharmaceuticals
05/04/2006WO2006047503A2 Inhibitors of c-fms kinase
05/04/2006WO2006047479A2 C-fms kinase inhibitors
05/04/2006WO2006046039A2 Tetracyclic indole derivatives as antiviral agents
05/04/2006WO2006032994A3 Muscarinic receptor antagonists
05/04/2006CA2585113A1 Tetracyclic indole derivatives as antiviral agents
05/03/2006EP1651633A1 Substituted lactams and their use as anti-cancer agents
05/03/2006CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents)
04/2006
04/27/2006WO2005096709A3 A process for the preparation of 10,11-dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide
04/27/2006US20060089357 Novel compounds and compositions as cathepsin inhibitors
04/27/2006US20060089347 Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
04/27/2006US20060089346 Optionally fused aryl-substituted azepanones, oxazepanone or thiazepanones substituted with a dipeptide group, e.g., N2-[(3,5-difluorophenyl)acetyl]-N1-[(2R,3R)-2-(2,5-difluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl]-L-alaninamide; secretase inhibitors for treating Alzheimer's disease
04/26/2006EP1648872A2 Aryl fused azapolycyclic compounds
04/26/2006CN1253554C acidophilic bacteria strain with nitrile hydrolase activity
04/26/2006CN1253441C Protease inhibitors
04/25/2006US7034110 Method of identifying chemical compounds having selected properties for a particular application
04/19/2006EP1646623A2 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
04/19/2006EP1487801B1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo¬d|azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
04/19/2006CN1252050C Process for recovering caprolactam from aqueous caprolactam product using in situ prepared alkali amino caproate
04/18/2006US7030138 Benzamidine derivatives
04/18/2006US7030116 Compounds and compositions as cathepsin inhibitors
04/13/2006WO2005118549A3 Compounds having affinity for dopamine d3 receptor and uses thereof
04/13/2006US20060079505 Modulators of muscarinic receptors
04/13/2006US20060079499 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
04/13/2006DE19637425B4 Neue N-Vinyllactam-Derivate und deren Polymere New N-vinyl lactam derivatives and their polymers
04/12/2006EP1644321A2 New benzamides as ppaty modulators
04/12/2006EP0903337B1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
04/12/2006CN1759101A Quinolinone / benzoxazinone derivatives and uses thereof
04/12/2006CN1758942A Distillative method for separating hexamethylenediamine from a mixture comprising hexamethylenediamine, -aminocapronitrile and tetrahydroazepine
04/12/2006CN1250528C Cyclic nitrones and pharmaceutical compositions containing them
04/11/2006US7026474 Method for producing ε-caprolactam and method for reactivating catalyst for production of ε-caprolactam
04/11/2006US7026473 Process for the carbonylation of pentenenitrile
04/11/2006US7026358 Oral general anesthetics and metabolitically resistant anticonvulsants
04/11/2006CA2322558C Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 88